[Skip to Content]
[Skip to Content Landing]
December 1982

Implications of Nuclear Magnetic Resonance Imaging for the Pediatrician

Author Affiliations

Department of Radiology and Radiological Sciences Vanderbilt University Medical Center Nashville, TN 37232 and Chairman of Medical Imaging Committee Children's Cancer Study Group University of Southern California School of Medicine Los Angeles, CA 90031; Departments of Radiology and Radiological Sciences and Biomedical Engineering; Department of Medical Administration and Vanderbilt Institute for Public Policy Studies Vanderbilt University Medical Center Nashville, TN 37232

Am J Dis Child. 1982;136(12):1045-1046. doi:10.1001/archpedi.1982.03970480011001

A 4-year-old child has been followed up in an oncology clinic for 18 months for chemotherapy and radiation therapy for stage III Wilms' tumor. As part of her routine clinic visit, a chest roentgenogram is obtained, and a new finding, a nodule, is observed in the right upper lung field. The pediatrician/oncologist has to decide whether the lung lesion should be considered to be metastatic Wilms' tumor or something else. Soon, there may be a new option, ie, nuclear magnetic resonance, which has the potential for distinguishing between benign and malignant tissue. If the lesion is benign, probably a histoplasmoma, nothing needs to be done. On the other hand, if the lesion is malignant, there are profound implications in terms of treatment plans.